A carregar...
Pembrolizumab-induced Myositis in the Setting of Metastatic Melanoma: An Increasingly Common Phenomenon
Pembrolizumab, an anti-programmed cell death protein 1 (PD-1) antibody, has demonstrated efficacy in treating metastatic melanoma. However, a handful of case reports have been published reporting autoimmune phenomena weeks after administration of the first dose of this immunomodulator. Although immu...
Na minha lista:
| Publicado no: | J Clin Aesthet Dermatol |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Matrix Medical Communications
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7442312/ https://ncbi.nlm.nih.gov/pubmed/32884619 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|